Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Povorcitinib for Vitiligo: Promising Study Results
October 2025
Discover a study on oral povorcitinib for vitiligo, showing significant repigmentation and safety in patients with extensive nonsegmental vitiligo.
Read more
7 Apr 2025
Newer Biologics Reduce Infection Risk in Patients with Psoriasis
The study assessed the risk of hospitalisation for serious infections based on different categories of systemic medications.
3 Apr 2025
Evaluating 3D Total-Body Photography for Melanoma Detection
The results indicated that 3D total-body photography reduced the number of melanoma excisions compared to controls.
30 Mar 2025
Risk Factor Count Determines Skin Cancer Progression
From a therapeutic perspective, these findings advocate for a more tailored approach to treatment.
28 Mar 2025
Spesolimab: A Breakthrough in Treating Generalised Pustular Psoriasis
Spesolimab, a monoclonal antibody targeting the interleukin (IL)-36 receptor, has been approved as the first GPP-specific therapy.
26 Mar 2025
Acne Scar Treatment: 70% or 100% Trichloroacetic Acid?
The findings of this study suggest that both 70% and 100% TCA achieve similar overall results.
24 Mar 2025
HPV Vaccination Reduces Actinic Keratosis Burden
Results suggest that standard HPV vaccination may offer a novel approach to actinic keratosis management.
20 Mar 2025
Psoriasis Treatment Study Confirms Biosimilar Effectiveness
Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira.
18 Mar 2025
Melanoma Disparities in Veterans: Understanding the Impact
A national cohort study found that veterans in the most disadvantaged areas had a higher risk of being diagnosed with thicker melanomas.
Loading posts...
« Previous
1
…
9
10
11
12
13
…
37
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View